Sintx Technologies (NASDAQ:SINT) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Sintx Technologies (NASDAQ:SINT) posted its quarterly earnings data on Tuesday. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.73) by ($0.02), FiscalAI reports. The business had revenue of $0.45 million during the quarter, compared to analysts’ expectations of $0.46 million. Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%.

Sintx Technologies Price Performance

Shares of NASDAQ:SINT traded up $0.07 during mid-day trading on Tuesday, reaching $1.77. 2,419,937 shares of the company traded hands, compared to its average volume of 39,529. The company’s 50 day moving average price is $1.83 and its 200-day moving average price is $2.39. The firm has a market cap of $7.65 million, a PE ratio of -0.35 and a beta of 0.62. Sintx Technologies has a 52 week low of $1.40 and a 52 week high of $6.78.

Hedge Funds Weigh In On Sintx Technologies

A hedge fund recently raised its position in Sintx Technologies stock. Geode Capital Management LLC grew its position in Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,624 shares of the company’s stock after purchasing an additional 9,265 shares during the quarter. Geode Capital Management LLC owned approximately 0.72% of Sintx Technologies worth $103,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 18.38% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on SINT shares. Maxim Group reaffirmed a “buy” rating and set a $6.00 target price on shares of Sintx Technologies in a report on Thursday, June 4th. HC Wainwright reiterated a “buy” rating and set a $10.00 price target on shares of Sintx Technologies in a research note on Wednesday, May 20th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $9.33.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.